Literature DB >> 32101049

microRNA Expression Profiling Based on Microarray Approach in Human Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Hao Zhou1,2, Cheng Peng1, De-Sheng Huang1,3, Lei Liu1,4, Peng Guan1.   

Abstract

Diabetes mellitus (DM) is one of the growing public health threats globally and as one of the common serious microvascular complications of DM, diabetic retinopathy (DR) is the leading cause of irreversible visual impairments and blindness. There is growing concern about the role of microRNAs (miRNAs) in the pathogenesis of DR. This meta-analysis was designed to collect those published miRNA expression profiling studies that compared the miRNA expression profiles in the biological samples of DR patients with those in the control group. Eight publications were finally included in the meta-analysis, and a total of 93 differentially expressed miRNAs were reported. Although six miRNAs were reported in at least two studies and with the consistent direction, after stratification by the type of biological samples, miR-320a was consistently reported to be upregulated in two serum sample-based studies and miR-423-5p was consistently reported to be upregulated in two vitreous humor sample-based studies. miR-27b was consistently reported to be downregulated in two serum sample-based studies. In conclusion, the results of this meta-analysis of human DR miRNAs' expression profiling studies might provide some clues of the potential biomarkers of DR. Further investigation of the mechanisms of miRNAs and more external validation studies are warranted with the aim of developing new diagnostic markers for preventing or reversing DR.

Entities:  

Keywords:  diabetic retinopathy; meta-analysis; microRNAs; profiling

Year:  2020        PMID: 32101049     DOI: 10.1089/dna.2019.4942

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  6 in total

1.  MicroRNA-375 repression of Kruppel-like factor 5 improves angiogenesis in diabetic critical limb ischemia.

Authors:  Michael G McCoy; Anurag Jamaiyar; Grasiele Sausen; Henry S Cheng; Daniel Pérez-Cremades; Rulin Zhuang; Jingshu Chen; Philip P Goodney; Mark A Creager; Marc S Sabatine; Marc P Bonaca; Mark W Feinberg
Journal:  Angiogenesis       Date:  2022-09-08       Impact factor: 10.658

2.  Dysregulation of miR-210 is involved in the development of diabetic retinopathy and serves a regulatory role in retinal vascular endothelial cell proliferation.

Authors:  Chengyu Yin; Xiangqiang Lin; Yafei Sun; Xinli Ji
Journal:  Eur J Med Res       Date:  2020-05-29       Impact factor: 2.175

3.  Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.

Authors:  E Pathak; R Mishra
Journal:  J Endocrinol Invest       Date:  2021-10-20       Impact factor: 5.467

Review 4.  Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy.

Authors:  Jinghua Jiao; Honghua Yu; Litong Yao; Lihua Li; Xiaohong Yang; Lei Liu
Journal:  J Inflamm Res       Date:  2021-12-16

Review 5.  Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis.

Authors:  Lingli Ma; Yan Wen; Zimeng Li; Nan Wu; Qing Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-08       Impact factor: 6.055

6.  MicroRNA Expression in the Aqueous Humor of Patients with Diabetic Macular Edema.

Authors:  Giuseppina Emanuela Grieco; Guido Sebastiani; Chiara Maria Eandi; Giovanni Neri; Laura Nigi; Noemi Brusco; Romina D'Aurizio; Matteo Posarelli; Tommaso Bacci; Elena De Benedetto; Mario Fruschelli; Maurizio Orlandini; Federico Galvagni; Francesco Dotta; Gian Marco Tosi
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.